220
Participants
Start Date
June 1, 2023
Primary Completion Date
April 30, 2026
Study Completion Date
April 30, 2026
Alcohol consumption
After written consent, patients will enter a run-in period of 2 weeks where they will be asked not to drink any alcohol beverage. Patients with a successful run-in period will be randomized on a 1:1 basis stratified by baseline LVEF (\<50% vs. ≥50%), sex and study site. 110 patients will be assigned to moderate alcohol consumption (1 standard unit a day), and 110 patients to abstinence (no alcohol beverages) for 3 months. We will perform a first echocardiography at randomization and a second at 3 months' follow-up.
RECRUITING
Centre hospitalier universitaire vaudois, Lausanne
RECRUITING
Hôpitaux Universitaires de Genève, Geneva
RECRUITING
Inselspital, Bern
Lead Sponsor
University of Bern
OTHER
Swiss National Science Foundation
OTHER
Baris Gencer
OTHER